Cancer Research  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 176-186, January 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phillips, D. H.
Right arrow Articles by Adams, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phillips, D. H.
Right arrow Articles by Adams, B.

Structures of the DNA Adducts Formed in Mouse Liver after Administration of the Proximate Hepatocarcinogen 1'-Hydroxyestragole1

David H. Phillips2, James A. Miller3, Elizabeth C. Miller and Bruce Adams

McArdle Laboratory for Cancer Research, and Department of Chemistry, University of Wisconsin, Madison, Wisconsin 53706

1'-Hydroxyestragole is a proximate carcinogenic metabolite of the naturally occurring hepatocarcinogen estragole (1-allyl-4-methoxybenzene). Two major (I and II) and 2 minor (III and IV) nucleoside adducts were found by high-performance liquid chromatography (HPLC) of enzymatic hydrolysates of hepatic DNA isolated from adult female CD-1 or preweanling C57BL/6 x C3H/He F1 mice that had been given i.p. injections of 1'-[2',3'-3H]hydroxyestragole. Reaction of 1'-acetoxyestragole, a model electrophilic and mutagenic ester, with [14C]deoxyguanosine ([14C]dGuo) yielded products that coeluted on HPLC with Adducts I, II, and III, while Adduct IV coeluted with a product of the reaction of 1'-acetoxyestragole with [14C]deoxyadenosine. The in vivo adducts did not comigrate with any major reaction products of either 1'-hydroxyestragole-2',3'-oxide or 1'-oxoestragole with [14C]dGuo or [14C]deoxyadenosine. The pH partition coefficient patterns of the in vivo- and in vitro-derived dGuo Adducts I, II, and III together with the 3H:14C ratios of the three adducts from the reaction of 1'-acetoxyestragole with [8-14C,8-3H]dGuo indicated that each of these adducts contains a N2-substituted dGuo residue. Synthetic samples of Adducts II and IV were characterized from their nuclear magnetic resonance spectra and assigned the structures N2-(trans-isoestragol-3'-yl)deoxyguanosine and N2-(trans-isoestragol-3'-yl)deoxyadenosine, respectively. Hydrolysis at 100° with 0.1 N HCl for 30 min of the in vivo Adducts I and II yielded in each case radioactivity which coeluted on HPLC with 3'-hydroxyisoestragole. If Adduct I was first reduced with H2:platinum and then hydrolyzed, radioactivity eluted with 1'-hydroxy-2',3'-dihydroestragole. Adduct I is therefore assigned the structure N2-(estragol-1'-yl)deoxyguanosine. Adduct III was converted in part to Adduct II on chromatography on HPLC and is thus tentatively regarded as N2-(cis-isoestragol-3'-yl)deoxyguanosine. All four adducts in the mouse liver can be accounted for by the reaction of a metabolically derived ester of 1'-hydroxyestragole with purine bases in DNA by SN1, SN2, or SN2' mechanisms.

1 This work was supported by Grants CA-07175 and CA-22484 from the National Cancer Institute, USPHS.

2 Present address: Department of Biological Sciences, Stanford University, Stanford, Calif. 94305.

3 To whom requests for reprints should be addressed.

Received 8/ 9/80. Accepted 10/ 8/80.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
S.G. Kim, A. Liem, B.C. Stewart, and J.A. Miller
New studies on trans-anethole oxide and trans-asarone oxide
Carcinogenesis, July 1, 1999; 20(7): 1303 - 1307.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.